|
1
|
Termsinsuk P, Charatcharoenwitthaya P and
Pausawasdi N: Development and validation of a 90-day mortality
prediction model following endobiliary drainage in patients with
unresectable malignant biliary obstruction. Front Oncol.
12:9223862022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Farani M, Saldi SRF, Maulahela H, Abdullah
M, Syam AF and Makmum D: Survival, stent patency, and
cost-effectiveness of plastic biliary stent versus metal biliary
stent for palliation in malignant biliary obstruction in a
developing country tertiary hospital. JGH Open. 5:959–965. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dar FS, Abbas Z, Ahmed I, Atique M, Aujla
UI, Azeemuddin M, Aziz Z, Bhatti ABH, Bangash TA, Butt AS, et al:
National guidelines for the diagnosis and treatment of hilar
cholangiocarcinoma. World J Gastroenterol. 30:1018–1042. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Drapek LC, Kerlan RK Jr and Acquisto S:
Guidelines for biliary stents and drains. Chin Clin Oncol. 9:92020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harvey PR, Baldwin S, Mytton J, Dosanjh A,
Evison F, Patel P and Trudgill NJ: Higher volume providers are
associated with improved outcomes following ERCP for the palliation
of malignant biliary obstruction. EClinicalMedicine. 18:1002122020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
On W, Saleem MA, Hegade VS, Huggett MT,
Paranandi B and Everett SM: Factors predicting 30-day mortality
after ERCP in patients with inoperable malignant hilar biliary
obstruction: A single tertiary referral centre experience and
systematic review. BMJ Open Gastroenterol. 9:e0008782022.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lam R and Muniraj T: Fully covered metal
biliary stents: A review of the literature. World J Gastroenterol.
27:6357–6373. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee TH, Moon JH and Park SH: Biliary
stenting for hilar malignant biliary obstruction. Dig Endosc.
32:275–286. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalaitzakis E: All-cause mortality after
ERCP. Endoscopy. 48:987–994. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu Z, Hu K, Zhao F, Liu W, Zhou H, Zhu Z
and Li H: Machine learning-based nomogram for 30-day mortality
prediction for patients with unresectable malignant biliary
obstruction after ERCP with metal stent: A retrospective
observational cohort study. BMC Surg. 23:2602023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo Y, Tan H, Yu T, Tian J and Shi H: A
novel artificial neural network prognostic model based on a
cancer-associated fibroblast activation score system in
hepatocellular carcinoma. Front Immunol. 13:9270412022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rajula HSR, Verlato G, Manchia M,
Antonucci N and Fanos V: Comparison of conventional statistical
methods with machine learning in medicine: Diagnosis, drug
development, and treatment. Medicina (Kaunas). 56:4552020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ataei A, Deng J and Muhammad W: Liver
cancer risk quantification through an artificial neural network
based on personal health data. Acta Oncol. 62:495–502. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kitano R, Inoue T, Ibusuki M, Kobayashi Y,
Ohashi T, Sumida Y, Nakade Y, Ito K and Yoneda M: Safety and
efficacy of endoscopic retrograde cholangiopancreatography in
patients with performance status 4. Dig Dis Sci. 66:1291–1296.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kumada T, Toyoda H, Tada T, Yasuda S and
Tanaka J: Changes in background liver function in patients with
hepatocellular carcinoma over 30 years: Comparison of child-pugh
classification and albumin bilirubin grade. Liver Cancer.
9:518–528. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chan E, Neeman T and Thomson A: Follow-up
to determine unplanned hospitalization and complications after
endoscopic retrograde cholangiopancreatography. ANZ J Surg.
88:E142–E146. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Teoh AYB, Napoleon B, Kunda R, Arcidiacono
PG, Kongkam P, Larghi A, Van der Merwe S, Jacques J, Legros R,
Thawee RE, et al: EUS-Guided Choledocho-duodenostomy using lumen
apposing stent versus ERCP with covered metallic stents in patients
with unresectable malignant distal biliary obstruction: A
multicenter randomized controlled trial (DRA-MBO Trial).
Gastroenterology. 165:473–482. e4722023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu Z, Song J, Pi Y, Sun X, Liu M, Xiao Z
and Chen J: A risk prediction model for post-endoscopic retrograde
cholangiopancreatography pancreatitis after stent insertion for
malignant biliary obstruction: Development and validation. Dig Dis
Sci. 68:1574–1584. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krill TS, Crain R, Al-Saadi Y, Stubbs S,
Roark R, Chatila A, Haddad C, Kaushik C, Marcondes F, Guturu P and
Parupudi S: Predictors of 30-day readmission after inpatient
endoscopic retrograde cholangiopancreatography: A single-center
experience. Dig Dis Sci. 65:1481–1488. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou HF, Lu J, Zhu HD, Guo JH, Huang M, Ji
JS, Lv WF, Li YL, Xu H, Chen L, et al: Early warning models to
estimate the 30-day mortality risk after stent placement for
patients with malignant biliary obstruction. Cardiovasc Intervent
Radiol. 42:1751–1759. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanno Y, Koshita S, Ogawa T, Kusunose H,
Masu K, Sakai T, Yonamine K, Miyamoto K, Murabayashi T, Kozakai F,
et al: Inside plastic stents versus metal stents for treating
unresectable malignant perihilar biliary obstructions: A
retrospective comparative study. Clin Endosc. 53:735–742. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park CH, Park SW, Jung JH, Jung ES, Kim JH
and Park DH: Comparative efficacy of various stents for palliation
in patients with malignant extrahepatic biliary obstruction: A
systematic review and network meta-analysis. J Pers Med. 11:862021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gong M, Li Q, Xu Y and Fu Y: The
evaluation of clinical status of endoscopic retrograde
cholangiography for the placement of metal and plastic stents in
cholangiocarcinoma therapy. Comput Math Methods Med.
2022:57414372022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Serghiou S and Rough K: Deep learning for
epidemiologists: An introduction to neural networks. Am J
Epidemiol. 192:1904–1916. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang H, Guo J, Li J, Li C, Du W, Canavese
F, Baker C, Ying H and Hua J: Artificial neural network modeling to
predict neonatal metabolic bone disease in the prenatal and
postnatal periods. JAMA Netw Open. 6:e22518492023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu X, Wang X, Yu L, Hou Y, Jiang Y, Wang
X, Han J and Yang Z: A novel prognostic score based on artificial
intelligence in hepatocellular carcinoma: A long-term follow-up
analysis. Front Oncol. 12:8178532022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tu JV: Advantages and disadvantages of
using artificial neural networks versus logistic regression for
predicting medical outcomes. J Clin Epidemiol. 49:1225–1231. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao B, Zhang KC, Wei B and Chen L: Status
quo and future prospects of artificial neural network from the
perspective of gastroenterologists. World J Gastroenterol.
27:2681–2709. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pergialiotis V, Pouliakis A, Parthenis C,
Damaskou V, Chrelias C, Papantoniou N and Panayiotides I: The
utility of artificial neural networks and classification and
regression trees for the prediction of endometrial cancer in
postmenopausal women. Public Health. 164:1–6. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Canakis A and Sharaiha RZ: Radiofrequency
ablation for pancreatobiliary disease: An updated review. Ann
Gastroenterol. 36:497–503. 2023.PubMed/NCBI
|
|
31
|
Nabi Z and Reddy DN: Endoscopic palliation
for biliary and pancreatic malignancies: Recent advances. Clin
Endosc. 52:226–234. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grein JD and Murthy RK: New developments
in the prevention of gastrointestinal scope-related infections.
Infect Dis Clin North Am. 32:899–913. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Labib PL, Goodchild G and Pereira SP:
Molecular pathogenesis of cholangiocarcinoma. BMC Cancer.
19:1852019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Özcan Ö and Arikan S: Determining the risk
factors of complications due to endoscopic retrograde
cholangiopancreatography. Cureus. 16:e516662024.PubMed/NCBI
|
|
35
|
Agrawal S, Gupta A, Gupta S, Goyal B,
Siddeek RAT, Rajput D, Chauhan U, Kishore S, Gupta M and Kant R:
Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and
carbohydrate antigen 125 as the predictors of resectability and
survival in the patients of carcinoma gall bladder. J Carcinog.
19:42020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bekki Y, Von Ahrens D, Takahashi H,
Schwartz M and Gunasekaran G: Recurrent intrahepatic
cholangiocarcinoma-review. Front Oncol. 11:7768632021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang H, Li W, Ren L, Yang Y, Zhang Y, Ge
B, Li S, Zheng X, Liu J, Zhang S, et al: Progress on diagnostic and
prognostic markers of pancreatic cancer. Oncol Res. 31:83–99. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kubo S, Shinkawa H, Asaoka Y, Ioka T,
Igaki H, Izumi N, Itoi T, Unno M, Ohtsuka M, Okusaka T, et al:
liver cancer study group of japan clinical practice guidelines for
intrahepatic cholangiocarcinoma. Liver Cancer. 11:290–314. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu J, Wang D, Liu C, Huang R, Gao F, Feng
X, Lan T, Li H and Wu H: Development and validation of a new
prognostic immune-inflammatory-nutritional score for predicting
outcomes after curative resection for intrahepatic
cholangiocarcinoma: A multicenter study. Front Immunol.
14:11655102023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bai Z, Yin Y, Xu W, Cheng G and Qi X:
Predictive model of in-hospital mortality in liver cirrhosis
patients with hyponatremia: An artificial neural network approach.
Sci Rep. 14:287192024. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Xu T and Wang X, Jia X, Ren M and
Wang X: The prognostic utility of preoperative
neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal
liver metastasis: A systematic review and meta-analysis. Cancer
Cell Int. 23:392023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Saputra HM, Hidayatullah F, Kloping YP,
Renaldo J, Chung E and Hakim L: Prognostic value of
neutrophil-to-lymphocyte ratio (NLR) in penile cancer: A systematic
review and meta-analysis. Ann Med Surg (Lond).
81:1043352022.PubMed/NCBI
|
|
43
|
Buonacera A, Stancanelli B, Colaci M and
Malatino L: Neutrophil to lymphocyte ratio: An emerging marker of
the relationships between the immune system and diseases. Int J Mol
Sci. 23:36362022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu L, Saxena S and Singh RK: Neutrophils
in the tumor microenvironment. Adv Exp Med Biol. 1224:1–20. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mouchli M, Reddy S, Gerrard M, Boardman L
and Rubio M: Usefulness of neutrophil-to-lymphocyte ratio (NLR) as
a prognostic predictor after treatment of hepatocellular carcinoma.
Review article. Ann Hepatol. 22:1002492021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ney A, Garcia-Sampedro A, Goodchild G,
Acedo P, Fusai G and Pereira SP: Biliary strictures and
cholangiocarcinoma-untangling a diagnostic conundrum. Front Oncol.
11:6994012021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tarighati E, Keivan H and Mahani H: A
review of prognostic and predictive biomarkers in breast cancer.
Clin Exp Med. 23:1–16. 2023.PubMed/NCBI
|
|
48
|
Zu QQ, Zhang JX, Wang B, Ye W, Liu S and
Shi HB: Percutaneous transpapillary biliary stent placement for
distal malignant biliary obstruction: Outcomes and survival
analysis. Turk J Gastroenterol. 30:714–721. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Singh I, Chou JF, Capanu M, Park J, Yu KH,
Varghese AM, Park W, Zervoudakis A, Keane F, Rolston VS, et al:
Morbidity and mortality in patients with stage IV pancreatic
adenocarcinoma and acute cholangitis: Outcomes and risk
prognostication. Pancreatology. 24:608–615. 2024. View Article : Google Scholar : PubMed/NCBI
|
